A Phase 1, Randomized, 2-Period, 2-Sequence, Open Label, Single Dose, Cross-Over Study To Evaluate The Effect Of Food On Pharmacokinetics Of Tasocitinib (CP-690,550) Tablets In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 12 Oct 2010
At a glance
- Drugs Tofacitinib (Primary)
- Indications Ankylosing spondylitis; Crohn's disease; Plaque psoriasis; Psoriatic arthritis; Renal transplant rejection; Rheumatoid arthritis; Ulcerative colitis
- Focus Pharmacokinetics
- 12 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2010 Additional location [Singapore] identified as reported by ClinicalTrials.gov.
- 23 Sep 2010 Actual initiation date (Sep 2010) added as reported by ClinicalTrials.gov.